Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Gunma University J-Pharma |
---|---|
Information provided by: | Gunma University |
ClinicalTrials.gov Identifier: | NCT00698373 |
L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional information for the preoperative diagnostic workup as compared with 18F-FDG PET. Tumor uptake of 18F-FMT was compared with several immunohistochemical markers including L-type amino acid transporter 1 (LAT1).
Condition |
---|
Non-Small Cell Lung Cancer |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Evaluation of Thoracic Tumors With 18F-FMT and 8F-FDG PET-CT: A Clinicopathological Study |
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with indeterminate pulmonary nodule suspicious of lung cancer were eligible for this prospective study.
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | Molecular FMT imaging |
Study First Received: | June 12, 2008 |
Last Updated: | June 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00698373 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Fluorine-18-α-methyltyrosine, Positron emission tomography, Fluorine-18-fluorodeoxyglucose, Lung cancer, |
Thoracic Neoplasms Non-small cell lung cancer Respiratory Tract Diseases Lung Neoplasms Lung Diseases |
Fluorides Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial Carcinoma |
Respiratory Tract Neoplasms Neoplasms Neoplasms by Site Neoplasms by Histologic Type |